Drugs / Abiraptor
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07104617 Background | Aug 2025 → Oct 2026 expected | prostate carcinoma | TYK Medicines, Inc | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Abiraptor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07104617 ↗ |
| Route | Oral | “Take orally, 1000mg each time, once a day” NCT07104617 ↗ |